Focus Financial Network Inc. Has $1.05 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Focus Financial Network Inc. lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,901 shares of the financial services provider’s stock after selling 87 shares during the quarter. Focus Financial Network Inc.’s holdings in iShares Biotechnology ETF were worth $1,045,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF in the 3rd quarter worth $30,000. HHM Wealth Advisors LLC boosted its stake in iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares during the period. Newbridge Financial Services Group Inc. bought a new position in iShares Biotechnology ETF during the 4th quarter worth about $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at about $34,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $135.47 on Thursday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The stock’s 50-day moving average is $135.88 and its 200-day moving average is $141.13.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.